Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis. [electronic resource]
Producer: 20061201Description: 204-13 p. digitalISSN:- 0300-8428
- Angiogenesis Inducing Agents -- pharmacology
- Animals
- Cardiac Output, Low -- prevention & control
- Coronary Vessels -- drug effects
- Dipeptides -- pharmacology
- Disease Models, Animal
- Echocardiography
- Enzyme Activation -- drug effects
- Hypertrophy, Left Ventricular -- drug therapy
- Immunoblotting
- Matrix Metalloproteinase 14 -- metabolism
- Matrix Metalloproteinase 2 -- metabolism
- Matrix Metalloproteinase Inhibitors
- Matrix Metalloproteinases -- metabolism
- Neovascularization, Physiologic -- drug effects
- Protease Inhibitors -- pharmacology
- Rabbits
- Time Factors
- Tissue Inhibitor of Metalloproteinases
- Vascular Endothelial Growth Factor A -- pharmacology
- Ventricular Pressure -- drug effects
- Ventricular Remodeling -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.